Publicaciones en las que colabora con GUILLERMO LÓPEZ VIVANCO (51)

2023

  1. Immunogenicity of COVID-19 vaccines in lung cancer patients

    Lung Cancer, Vol. 184

  2. Nurse-Supervised Exercise for People with Stage IV Cancer: The EFICANCER Randomized Clinical Trial

    Seminars in Oncology Nursing, Vol. 39, Núm. 4

2022

  1. Just an Acute Pulmonary Edema? Paraneoplastic Thyroid Storm Due to Invasive Mole

    Case Reports in Oncology, Vol. 15, Núm. 2, pp. 566-572

2019

  1. Germline c.1A>C heterozygous pathogenic variant in SDHA reported for the first time in a young adult with a gastric gastrointestinal stromal tumour (GIST): A case report

    Hereditary Cancer in Clinical Practice, Vol. 17, Núm. 1

2018

  1. Infective endocarditis in a patient with metastatic colorectal cancer

    Revista Espanola de Quimioterapia

2017

  1. Epithelial ovarian cancer and primary peritoneal carcinomatosis in the elderly: What is our clinical practice?

    European Journal of Gynaecological Oncology, Vol. 38, Núm. 5, pp. 695-699

  2. Hereditary pancreatic cancer: Related syndromes and clinical perspective

    Hereditary Cancer in Clinical Practice, Vol. 15, Núm. 1

2015

  1. Efficacy and safety of fixed-dose-rate infusions of gemcitabine plus erlotinib for advanced pancreatic cancer

    Journal of Analytical Oncology, Vol. 4, Núm. 1, pp. 44-51

  2. Supervised physical exercise to improve the quality of life of cancer patients: The Eficancer randomised controlled trial

    BMC Cancer, Vol. 15, Núm. 1

2014

  1. Bevacizumab in combination with FOLFIRI in the first-line treatment of patients with advanced colorectal cancer: A single-institution experience

    Journal of Analytical Oncology, Vol. 3, Núm. 1, pp. 26-32

  2. Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: Biological basis and therapeutic strategies

    Clinical and Translational Oncology, Vol. 16, Núm. 4, pp. 339-350

  3. Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer

    PLoS ONE, Vol. 9, Núm. 10

2013

  1. Thymidylate Synthase Expression Determines Pemetrexed Targets and Resistance Development in Tumour Cells

    PLoS ONE, Vol. 8, Núm. 5

2012

  1. Molecular mechanism implicated in Pemetrexed-induced apoptosis in human melanoma cells

    Molecular Cancer, Vol. 11

2010

  1. Fixed-dose-rate gemcitabine infusion in patients with advanced pancreatic or biliary tree adenocarcinoma

    Tumori, Vol. 96, Núm. 3, pp. 405-410

2009

  1. Identification of potential diagnostic markers in bronchial fluid of patients with non small cell lung cancer (NSCLC)

    EJC SUPPLEMENTS

  2. Potential diagnostic markers in bronchial fluid of small cell lung cancer (SCLC)

    EJC SUPPLEMENTS

  3. Systematic treatment of the central nervous system metastases in lung cancer

    Cancer and Chemotherapy Reviews, Vol. 4, Núm. 1, pp. 3-11

2008

  1. Prognostic factors in cancer of unknown primary site

    Clinical and Translational Oncology

2007

  1. Efficacy and safety of cisplatin and capecitabine in combination as first line treatment for unselected patients with advanced gastric cancer [3]

    Acta Oncologica